SubjectWell

It's no secret that patient recruitment remains one of the biggest hurdles in clinical research, with 30% of trials terminated due to enrollment issues, and 80% failing to meet recruitment goals entirely. So how can sponsors engage the right patients, faster? In his latest article, Dr. Tobias Kruse explains how targeted outreach, patient-centric engagement, and protocol-driven creative strategies can transform recruitment success. Find out what it takes to optimize patient enrollment here:? https://lnkd.in/eZMQ_t9b

Patient voices matter. And for Rare Disease Day, we’re amplifying a story close to home. In her latest article, Suzanne Harris, SubjectWell’s own SVP of Marketing, shares her personal journey as a rare disease patient, the challenges of navigating the healthcare system, and the critical need for patient-centricity in clinical research. Her experience is a powerful reminder that behind every study, treatment, and breakthrough is a real person with real needs. Read Suzanne’s story and join the conversation:

Today is Rare Disease Day. With 6,000+ identified rare diseases affecting 300 million people worldwide, we’re reminded that rare is not so rare. 70% of these diseases start in childhood, impacting families, futures, and access to care. SubjectWell is using today—and every day—to amplify the voices of the rare disease community. We stand with those living with rare diseases by raising awareness, advocating for change, and working toward a more equitable future in clinical research. #RareDiseaseDay

When a Phase I Relapsing-Remitting Multiple Sclerosis study needed a recruitment boost, SubjectWell delivered. If SubjectWell had been involved from the start, the sponsor could have saved 6 months of recruitment time! Don’t leave recruitment to chance—see how we’re changing the game. Check out our case studies and learn more: https://lnkd.in/edXrh6hx

Secondary Screening is transforming patient recruitment by improving referral quality and reducing site burden. For example, referrals generated via Secondary Screening are 68% more likely to schedule an appointment compared to standard web-screened referrals. This process also enables a 42-48% reduction in referral volume, which mitigates site overload while maintaining study performance. Read the case study in full to see how SubjectWell's optimized secondary screening enhances trial outcomes: https://lnkd.in/e9mu7b7K

Today, on National Caregivers Day, we recognize the 53+ million Americans who dedicate their time and energy to caring for family members. Caregiving is a profound act of dedication that comes with both challenges and rewards. We believe caregivers deserve support just as much as the patients they care for. That’s why we’re dedicated to making clinical research more accessible so that patients and caregivers have opportunities to explore new treatment options that could improve their quality of life. To all the caregivers: we see you, we appreciate you, and we support you. ??

The future of clinical trial recruitment is here. SubjectWell is?redefining patient recruitment by building the world’s largest network of pre-screened, engaged, and consented patients across every therapeutic area and health condition. Our approach ensures faster, more efficient enrollment while keeping the patient experience at the heart of everything we do. Because better recruitment means better research. And better research leads to better treatments, faster. Get to know the new SubjectWell in our latest brand video. We’re not just transforming clinical trials—we’ve transformed, too!

At SubjectWell, we believe that everyone deserves access to clinical research. Black and African American communities have historically been underrepresented in research, despite facing disproportionate burdens for many health conditions. ? We’re committed to changing that. We're working to ensure clinical trials better reflect the real world through inclusive outreach, patient-first engagement, and a vast, diverse network of trial-ready participants. Because better representation leads to better health outcomes for all. ? This Black History Month, we reaffirm our dedication to health equity, accessibility, and increasing diverse participation in clinical research. Together, we can drive meaningful change.

That's a wrap on SCOPE! Our team had an amazing experience connecting with industry leaders, exchanging insights, and celebrating the excitement around our rebrand. This year’s conference was packed with insightful discussions, meaningful connections, and a shared commitment to driving innovation in clinical research. Here are some key themes that stood out to our team: 1?? Diversity in clinical trials: Regardless of political developments, there is a shared consensus that representation is essential, especially in research. 2?? Data, data, data: With so much data at our fingertips, how can we make the best use of it to drive meaningful change in patient outcomes? 3?? Patient-centricity: Keeping patients at the heart of every decision remains our guiding principle. 4?? Partnerships: Genuine collaboration isn’t just business as usual, but about working together to make a real impact on patient lives. A huge thank you to everyone who stopped by, chatted with us, and helped make this event such a success! We're looking forward to continuing these important conversations. See you next year!

SubjectWell 2.0 is more than a new look. It’s a movement to drive real change for patients. With cutting-edge technology, expanded global reach, and enhanced site and patient support, we’re redefining what’s possible in clinical trial recruitment. Our CEO,?Fred Martin,?shares the steps we’re taking to transform the industry in this article: